Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Hansen

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Diabetes Research and Clinical Practice|August 12, 2011
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failureCharlotte Andersson, Gunnar H Gislason, Casper H Jørgensen, et al.
European Journal of Heart Failure|September 25, 2010
Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort studyCharlotte Andersson, Mette L Norgaard, Peter R Hansen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2018
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segmentsLars Kjøller-Hansen, Niels Bligaard, Henning Kelbæk, et al.
Journal of the American College of Cardiology|February 24, 2009
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trialDan Atar, Peter Petzelbauer, Jürg Schwitter, et al.
BMC Cardiovascular Disorders|February 2, 2010
Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort studyRikke Sørensen, Steen Z Abildstrom, Peter Weeke, et al.
Circulation|September 12, 2012
Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort studyAnne-Marie Schjerning Olsen, Emil L Fosbøl, Jesper Lindhardsen, et al.
Journal of the American College of Cardiology|February 11, 2017
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary StentsAnders M Galløe, Henning Kelbæk, Leif Thuesen, et al.
Journal of Cardiovascular Computed Tomography|February 6, 2024
The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery diseaseMartina C de Knegt, Jesper J Linde, Per E Sigvardsen, et al.
Journal of the American Heart Association|September 29, 2021
Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT TrialJawad H Butt, Klaus F Kofoed, Henning Kelbæk, et al.
Microbiome|September 4, 2015
In silico analyses of metagenomes from human atherosclerotic plaque samplesSuparna Mitra, Daniela I Drautz-Moses, Morten Alhede, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Diabetes Research and Clinical Practice|August 12, 2011
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failureCharlotte Andersson, Gunnar H Gislason, Casper H Jørgensen, et al.
European Journal of Heart Failure|September 25, 2010
Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort studyCharlotte Andersson, Mette L Norgaard, Peter R Hansen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2018
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segmentsLars Kjøller-Hansen, Niels Bligaard, Henning Kelbæk, et al.
Journal of the American College of Cardiology|February 24, 2009
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trialDan Atar, Peter Petzelbauer, Jürg Schwitter, et al.
BMC Cardiovascular Disorders|February 2, 2010
Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort studyRikke Sørensen, Steen Z Abildstrom, Peter Weeke, et al.
Circulation|September 12, 2012
Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort studyAnne-Marie Schjerning Olsen, Emil L Fosbøl, Jesper Lindhardsen, et al.
Journal of the American College of Cardiology|February 11, 2017
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary StentsAnders M Galløe, Henning Kelbæk, Leif Thuesen, et al.
Journal of Cardiovascular Computed Tomography|February 6, 2024
The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery diseaseMartina C de Knegt, Jesper J Linde, Per E Sigvardsen, et al.
Journal of the American Heart Association|September 29, 2021
Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT TrialJawad H Butt, Klaus F Kofoed, Henning Kelbæk, et al.
Microbiome|September 4, 2015
In silico analyses of metagenomes from human atherosclerotic plaque samplesSuparna Mitra, Daniela I Drautz-Moses, Morten Alhede, et al.
Pageof 9